Recombinant human prourokinase

重组人尿激酶原

Report date: 2026/04/08 15:31:37

Base Information

Drug NameRecombinant human prourokinase
Drug Alias NameUrokinase (Shanghai Tably)rhPro-UKRecombinant Human Pro-urokinase普佑克B1101 +[8] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsIschemic StrokeMyocardial InfarctionPulmonary Embolism
Global Approved IndicationsMyocardial Infarction
Approved Indications in ChinaMyocardial Infarction
Original Approved Country/TerritoryMainland China
Original Approved Date2011/04/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTasly Biomedical Co LtdInstitute Of Bioengineering, Academy Of Military Medical Sciences
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTasly Biomedical Co Ltd
Inactive CompaniesTasly Biopharmaceuticals Co Ltd
Active IndicationsIschemic StrokeMyocardial Infarction
Inactive IndicationsPulmonary Embolism

Other Information

ATC CodeB01AD04
Related LinksKEGG